MML Investors Services LLC Has $37.93 Million Stock Holdings in UnitedHealth Group Incorporated $UNH

Key Points

• MML Investors Services LLC cut its UnitedHealth Group stake by 20.9% in the fourth quarter, but still held 114,901 shares valued at about $37.93 million.
• UnitedHealth Group reported better-than-expected quarterly results, with EPS of $7.23 topping estimates and revenue of $111.65 billion, while also raising its quarterly dividend to $2.32 per share.
• Wall Street remains generally positive on UNH, with multiple firms raising price targets and the stock carrying a Moderate Buy consensus rating and average target price of about $407.17.

MML Investors Services LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 20.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 114,901 shares of the healthcare conglomerate's stock after selling 30,448 shares during the quarter. MML Investors Services LLC's holdings in UnitedHealth Group were worth $37,930,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the stock. Founders Capital Management LLC raised its position in shares of UnitedHealth Group by 3.0% during the fourth quarter. Founders Capital Management LLC now owns 982 shares of the healthcare conglomerate's stock worth $324,000 after acquiring an additional 29 shares during the last quarter. Kellett Wealth Advisors LLC grew its position in shares of UnitedHealth Group by 1.7% during the 4th quarter. Kellett Wealth Advisors LLC now owns 1,746 shares of the healthcare conglomerate's stock worth $576,000 after buying an additional 29 shares during the period. Cooper Financial Group increased its holdings in shares of UnitedHealth Group by 0.7% during the fourth quarter. Cooper Financial Group now owns 4,338 shares of the healthcare conglomerate's stock valued at $1,432,000 after acquiring an additional 30 shares in the last quarter. Successful Portfolios LLC increased its holdings in shares of UnitedHealth Group by 2.6% during the fourth quarter. Successful Portfolios LLC now owns 1,194 shares of the healthcare conglomerate's stock valued at $411,000 after acquiring an additional 30 shares in the last quarter. Finally, McLean Asset Management Corp increased its holdings in shares of UnitedHealth Group by 1.6% during the fourth quarter. McLean Asset Management Corp now owns 2,000 shares of the healthcare conglomerate's stock valued at $670,000 after acquiring an additional 32 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 800 shares of the firm's stock in a transaction that occurred on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the transaction, the chief executive officer directly owned 17,805 shares in the company, valued at $6,320,775. This trade represents a 4.30% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.28% of the stock is currently owned by insiders.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $411.32 on Tuesday. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.69. The stock has a market cap of $373.54 billion, a P/E ratio of 31.07, a PEG ratio of 1.64 and a beta of 0.64. The business's 50-day moving average price is $364.96 and its two-hundred day moving average price is $327.51. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $415.98.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, beating the consensus estimate of $6.76 by $0.47. The firm had revenue of $111.65 billion for the quarter, compared to analyst estimates of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The company's revenue was up 2.0% on a year-over-year basis. During the same period in the prior year, the company earned $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 18.32 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 23rd. Investors of record on Monday, June 15th will be given a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date is Monday, June 15th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.21. UnitedHealth Group's dividend payout ratio is 66.77%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on UNH shares. Sanford C. Bernstein upped their price target on UnitedHealth Group from $444.00 to $492.00 and gave the stock an "outperform" rating in a report on Wednesday, May 27th. Weiss Ratings upgraded UnitedHealth Group from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Thursday, May 7th. JPMorgan Chase & Co. upped their price target on UnitedHealth Group from $420.00 to $466.00 and gave the company an "overweight" rating in a research report on Monday, June 8th. Argus raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $400.00 price target on the stock in a research report on Wednesday, April 22nd. Finally, Oppenheimer increased their price objective on UnitedHealth Group from $385.00 to $405.00 and gave the stock an "outperform" rating in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, twenty have assigned a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $407.17.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.